"Injection consistency evaluation" new rules announced, the State Health Insurance Administration set a time limit for fee settlement, the Health and Planning Commission clear 10 "Internet and medical services" project charges; Wuhan epidemic ...

Guide: Injection consistency evaluation has become a policy focus this weekThis week
the State Drug Administration issued a "injection consistency evaluation" new rules
the State Health Insurance Administration: the cost settlement time limit does not exceed 30 working days
health and health committee issued a clear 10 "Internet and medical services" project and related fee-paying behavior
the wuhan epidemic rebound, the outbreak testing reagents enterprise stock market surge
the government to hearthe State Drug Administration issued "injection consistency evaluation" new rules
announcement pointed out that the listed chemical injection generic drugs, not in accordance with the original drug quality and efficacy of the principle of approval of varieties need to carry out a consistent evaluationThe holder of a drug listing license shall select the reference preparation according to the List of Generic Drug Reference Preparations issued by the State Drug Administration, and carry out a consistent evaluation of the research and development declarationhas not been included in the "generic drug reference preparation catalog" varieties, drug listing license holders should be in accordance with the "National Drug Administration on the issuance of chemical generic drug reference preparation selection and determination procedures" (No25 of 2019) to declare the reference preparations, pending the determination of the reference preparations to carry out a consistent evaluation of research and development declaration, to avoid the occurrence of reference preparation selection and national publication of the reference preparations, affecting the development of resources and other issuesa generic drug for chemical softos that are clearly of clinical value but cannot be determined, such as sodium chloride injections, glucose injections, sodium glucose chloride injections, and water injections, etc., does not require a consistency evaluationlinked to the base drug catalogue, 120 days to complete the review ..National Health Insurance Bureau: The time limit for the settlement of expenses does not exceed 30 working days
On May 12, the State Health Insurance Administration issued a Notice on the Issue of the National Medical Security Administration Service List (hereinafter referred to as the "National List"), divided into 10 main items and 28 sub-items , the time limit for the settlement of the expenses of the designated medical institutions (including medical institutions and retail pharmacies) shall not exceed 30 working days It is hoped that the problem of the settlement of medical insurance expenses of fixed-point medical institutions will be solved and the pressure of capital flow should be reduced At the same time, for the current medical security management of government services in the field of the existence of the process is not simplified norms, the transfer of insurance and manual reimbursement procedures cumbersome and long time cycle, off-site medical filing is not convenient, the experience of handling services is not ideal and other issues put forward new requirements "National List" covers the current medical security handling of the ten general service matters, has clearly handled the time limit of 26 sub-items, processing time limit than before the actual processing time limit has been greatly reduced, the overall compression ratio of more than 50% so that, by reducing the time limit for medical insurance settlement, the implementation of medical insurance fund advance, supervision of medical institutions timely repayment, the problem of arrears will be improved, reduce the pressure on the operation of enterprise funds And by the health insurance department and pharmaceutical companies to settle the money directly, will solve the triangular debt between hospitals, pharmaceutical companies, medical insurance the dynamic adjustment of the medical insurance catalog, focusing on monitoring the seven major coping strategies! May 12, the State Medical Insurance Administration issued the "Interim Measures for the Administration of Drug Use of Basic Medical Insurance (Draft for Comments)" deadline for comments pointed out that the state medical security administrative department has established and perfected the dynamic adjustment mechanism of the Basic Medical Insurance Drug Catalog, which in principle adjusts once a year Not long ago, Shanghai Sunshine Pharmaceutical Procurement Network published 20 negotiated prices higher than the lowest price of five provinces and cities of the list of drugs and 10 "National Drug Supply Guarantee Integrated Management Information Platform" without the price information of the provinces and cities of the list of drugs, and made it clear that if the production enterprises can not prove its reasonable price, will suspend the internet qualification , Beijing, Tianjin, Shandong, Sichuan and Hunan have announced the list of drugs transferred out of the medical insurance catalogue Hebei, Jiangxi, Anhui and other provinces will also be transferred in three years according to different proportions (40%, 40%, 20%), the drugs transferred out of the medical insurance list must be paid for by individuals so, the worst outcome of the focus on monitoring varieties is to bring up the health-care catalog Not being in the health-care list is certainly a great disadvantage, but it doesnot mean hopeless Unless willing to withdraw from the market, otherwise the relevant enterprises not only have to die and live the determination, but also have practical methods and strategies health and health committee issued a clear 10 "Internet and medical services" project and related charging behavior
May 14, "National Health and Health Commission of the State Administration of Traditional Chinese Medicine on the public medical institutions to do a good job in the "Internet and Medical Services" project technical specifications and financial management notice" officially issued Part 1 puts forward the management requirements of the "Internet plus Medical Services" project The 10 "Internet and Medical Services" projects have been identified, and the charging behavior of medical institutions to carry out related services has been standardized Part 2 puts forward the accounting and financial management requirements of "Internet and Medical Services" The distribution relationship of benefits, revenue recognition principle, financial processing and bill processing requirements of different subjects in the process of carrying out "Internet and medical services" are clarified Part 3 puts forward the workload statistics requirements after the implementation of "Internet plus medical services" After the inviting and inviting parties carry out the "Internet plus medical service", the workload statistics standards within the medical institutions and within the overall region are clarified Part 4 annex clearly defined the "Internet and Medical Services" project technical specification content, based on the "Internet Diagnostic and Therapeutic Management Measures (Trial)", "Internet Hospital Management Measures (Trial)" and "Remote Medical Service Management Code (Trial)" in the relevant technical requirements for clinical access good! The State Council requires hospitals to configure these equipment
On May 12, the State Council's Medical Treatment Group for the Joint Prevention and Control Mechanism for the New Coronary Pneumonia Outbreak issued a "Notice on the Promotion of Work Experience in the Construction and Management of Shanghai Fever Outpatient Clinics" to promote the work experience of the Shanghai Health and Health Commission in responding to the outbreak to the whole country notice indicates that hospitals at all levels should increase the configuration of fever clinics, should increase the number of medical personnel, such as internal medicine, emergency, imaging and other medical personnel, as well as related medical equipment document in particular pointed out that to gradually increase the CT configuration of fever outpatient, for the fever outpatient imaging examination capacity is insufficient, should be graded and gradually built, in accordance with the "first suburban hospital after urban hospital, first second-level hospital after the third-level hospital" principle configuration CT, equipment in stages to complete the installation at present, CT imaging results are an important reference standard for doctors as clinical diagnosis, and on the basis of CT scan, it is possible to predict recurrence in combination with AI on the clinical performance of patients market dynamics WHO: New coronavirus may become an epidemic virus that will never go away
13, said Michael Ryan, head of WHO's health emergency program, the new coronavirus may become a long-term problem, it is difficult to predict when the virus can be defeated, it may become an epidemic virus that will never disappear Michael Ryan says he hopes to develop a highly effective vaccine that will be distributed to everyone in the world 39 pharmaceutical enterprises in Anhui Province were inspected
On May 12, the Anhui Provincial Drug Administration issued a notice on drug production supervision and inspection information for the period january-April 2020, including 2 due-flight inspections; Shandong Province issued the latest prevention plan for new coronary pneumonia
On May 12, Shandong Province issued the "Shandong Province new coronavirus pneumonia Chinese medicine prevention and control program" (hereinafter referred to as the "Programme") The prevention and treatment of new coronaviruses are also proposed is worth noting that the Program in the treatment of a number of traditional Chinese medicine, including fennel positive gas (soft) capsules (pills, water, oral liquid), lianhua clear plague capsules (particles), golden flower clear particles, blue tantalum oral liquid, hydrophobic detoxification capsules (particles) and more than a dozen drugs corporate information for sale or a shell? Behind The 7.5 billion deal in Rohingya: Betting is the biggest test! Luoxin Pharmaceuticals 7.5 billion "backshell" listing behind, there are money-making pioneers, but also are facing pressure on the latter The more crucial protagonist is Luo Xin Pharmaceuticals itself, whose shell after the listing of the test has just begun May 12, Dongyin shares announced that the securities short will be officially renamed "Roxin Pharmaceuticals." This means that from May 2019, Luoxin Pharmaceutical "shell" Dongyin shares listed, finally have the results in fact, as early as December 31 last year, the China Securities Regulatory Commission has approved the listing of Luoxin Pharmaceuticals' shell Dongyin shares, this time only the end of the name Luo Xin Pharmaceuticals, a former GEM listed company on the Hong Kong Stock Exchange, applied to the Hong Kong Stock Exchange several times in February 2013, November 2013 and December 2015 to switch to the main board transaction, but this was rejected the rebound of the Wuhan outbreak, the outbreak detection reagent enterprise stock market surge
May 11, Wuhan New Crown Pneumonia Outbreak Prevention and Control Command epidemic-related big data and epidemiology investigation team issued "on the implementation of the city's new coronavirus nucleic acid screening emergency notice" (hereinafter referred to as "emergency notice"), which informed Wuhan District New Coronary Pneumonia Outbreak Prevention and Control Command: after research decision, in Wuhan City-wide to carry out full new coronavirus nucleic acid screening "10 days general assembly war." Each district according to the 10-day period, do a good job in this jurisdiction of the full nucleic acid screening program arrangements 12 morning, the new crown pneumonia monitoring concept rose alarmingly, the index straight below 4%, as of May 12, the close, Mike Bio, Nine Biology, Mingde Biological and many other ups and downs, Da'an gene rose more than 9%, Shushi Bio, Huada gene and other stocks have also pulled up 13, the concept gradually digested, the extent of the closing increase called the previous day's decline significantly, Mingde, Huada, Da'an and other three enterprises fell seriously, while in the previous few days in Hubei Province announced the new corona pneumonia nucleic acid testing reagents in the winning enterprises only Mike biostock market still showed last week's trend sources of information: Pharmaceutical News, Sina Pharmaceutical News, Seiber Blue, E Pharmaceutical Manager, Pharmaceutical Economic Sini, Shell Society and other responsibility editor , penicillin statement: This article is the integration of pharmaceutical intelligence network content, does not represent the views of this platform If the content of the work, copyright and other issues, please contact this public number message, we will delete the content in the first place related labels: national , injection , consistency evaluation , health insurance , vaccine 0
0